The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions
Open accessAbstract
Recent studies describing the seemingly contradictory actions of estrogens in ischemic stroke injury have led us to reevaluate the circumstances under which estrogen therapy (ET) provides benefits against cerebral stroke and decipher its mechanisms of action. One prominent feature that follows stroke injury is massive central and peripheral inflammatory responses. Evidence now suggests that postischemic inflammatory responses strongly contribute to the extent of brain injury, and 17β-estradiol (E 2 ) may protect the ischemic brain by exerting antiinflammatory actions. In an attempt to explain recently reported dichotomous effects of E 2 in stroke injury, we tested the hypothesis that an extended period of hypoestrogenicity both prevents E 2 from protecting the brain against ischemia and simultaneously suppresses its antiinflammatory actions. We report that E 2 exerts profound neuroprotective action when administered immediately upon ovariectomy, but not when administered after 10 weeks of hypoestrogenicity. Consistently, E 2 treatment given immediately at the time of ovariectomy attenuated central and peripheral production of proinflammatory cytokines after ischemic stroke. In contrast, E 2 did not suppress production of proinflammatory molecules when it was administered after 10 weeks postovariectomy. These results demonstrate that a prolonged period of hypoestrogenicity disrupts both neuroprotective and antiinflammatory actions of E 2 . Our findings may help to explain the results of the Women's Health initiative that reported no beneficial effect of ET against stroke because the majority of the subjects initiated ET after an extended period of hypoestrogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,204
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
Cytokines and acute neurodegeneration
Allan, S. M., & Rothwell, N. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094583 · Cited by 1,123
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
Vila, N., Castillo, J., Dávalos, A., & Chamorro, A. (2000) · Stroke · doi:10.1161/01.str.31.10.2325 · Cited by 675
Estradiol Protects against Ischemic Injury
Dubal, D. B., Kashon, M. L., Pettigrew, L. C., Ren, J. M., Finklestein, S. P., Rau, S. W., & Wise, P. M. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00012 · Cited by 554
Self-citationEstrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury
Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., Kindy, M. S., & Wise, P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1952 · Cited by 547
Self-citationExperimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System
Offner, H., Subramanian, S., Parker, S. M., Afentoulis, M. E., Vandenbark, A. A., & Hurn, P. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600217 · Cited by 536
Oestrogen as a neuroprotective hormone
Behl, C. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn846 · Cited by 488
Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors
Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., & Wise, P. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06385.1999 · Cited by 449
Self-citationEstrogen receptor-α mediates the brain antiinflammatory activity of estradiol
Vegeto, E., Belcredito, S., Etteri, S., Ghisletti, S., Brusadelli, A., Meda, C., Krust, A., Dupont, S., Ciana, P., Chambon, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531957100 · Cited by 382
The many faces of tumor necrosis factor in stroke
Hallenbeck, J. M. (2002) · Nature Medicine · doi:10.1038/nm1202-1363 · Cited by 367
Mueller, M. D., Vigne, J.-L., Minchenko, A., Lebovic, D. I., Leitman, D. C., & Taylor, R. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200377097 · Cited by 353
Fassbender, K., Rossol, S., Kammer, T., Daffertshofer, M., Wirth, S., Dollman, M., & Hennerici, M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90289-5 · Cited by 325
Estrogen and ischemic neuroprotection: an integrated view
McCullough, L. D., & Hurn, P. D. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00076-6 · Cited by 317
Hayashi, T., Abe, K., & Itoyama, Y. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00009 · Cited by 304
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Turgeon, J. L., McDonnell, D. P., Martin, K. A., & Wise, P. M. (2004) · Science · doi:10.1126/science.1096725 · Cited by 297
Self-citationKim, J. S., Gautam, S. C., Chopp, M., Zaloga, C., Jones, M. L., Ward, P. A., & Welch, K. M. A. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00138-e · Cited by 283
Chen, Y., Hallenbeck, J. M., Ruetzler, C., Bol, D., Thomas, K., Berman, N. E. J., & Vogel, S. N. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071885.63724.20 · Cited by 276
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Self-citationReynolds, M. A., Kirchick, H. J., Dahlen, J. R., Anderberg, J. M., McPherson, P. H., Nakamura, K. K., Laskowitz, D. T., Valkirs, G. E., & Buechler, K. F. (2003) · Clinical Chemistry · doi:10.1373/49.10.1733 · Cited by 235
An, J., Ribeiro, R. C. J., Webb, P., Gustafsson, J.-Å., Kushner, P. J., Baxter, J. D., & Leitman, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15161 · Cited by 203
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice
Che, X., Ye, W., Panga, L., Wu, D.-C., & Yang, G.-Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02328-9 · Cited by 201
Early TNF-α levels correlate with ischaemic stroke severity: TNF-α and stroke
Zaremba, J., & Losy, J. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00053.x · Cited by 193
Dubal, D. B., Rau, S. W., Shughrue, P. J., Zhu, H., Yu, J., Cashion, A. B., Suzuki, S., Gerhold, L. M., Bottner, M. B., Dubal, S. B., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1177 · Cited by 174
Self-citationNilsen, J., Chen, S., Irwin, R. W., Iwamoto, S., & Brinton, R. D. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-74 · Cited by 174
Mechanisms of Neuroprotection by Estrogen
Suzuki, S., Brown, C. M., & Wise, P. M. (2006) · Endocrine · doi:10.1385/endo:29:2:209 · Cited by 168
Self-citationThe Endogenous Estrogen Status Regulates Microglia Reactivity in Animal Models of Neuroinflammation
Vegeto, E., Belcredito, S., Ghisletti, S., Meda, C., Etteri, S., & Maggi, A. (2006) · Endocrinology · doi:10.1210/en.2005-1330 · Cited by 167
Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
Rau, S. W., Dubal, D. B., Böttner, M., Gerhold, L. M., & Wise, P. M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11420.2003 · Cited by 156
Self-citationWise, P. M., Dubal, D. B., Rau, S. W., Brown, C. M., & Suzuki, S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0014 · Cited by 148
Self-citationWilson, M. E., Dubal, D. B., & Wise, P. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02479-3 · Cited by 124
Self-citationTumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients
Intiso, D., Zarrelli, M. M., Lagioia, G., Rienzo, F. D., Ambrosio, C. C. D., Simone, P., Tonali, P., & Cioffi†, R. P. (2004) · Neurological Sciences · doi:10.1007/s10072-003-0194-z · Cited by 121
Chen, S., Nilsen, J., & Brinton, R. D. (2006) · Endocrinology · doi:10.1210/en.2006-0495 · Cited by 121
Członkowska, A., Ciesielska, A., Gromadzka, G., & Kurkowska‐Jastrzębska, I. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381693 · Cited by 116
Marklund, N., Peltonen, M., Nilsson, T. K., & Olsson, T. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01334.x · Cited by 104
Harman, S. M., Naftolin, F. N., Brinton, E. A., & Judelson, D. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.004 · Cited by 99
Hormone replacement therapy and stroke: risk, protection or no effect?
Paganini‐Hill, A. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00167-0 · Cited by 97
Kim, H., Shin, H., Jeong, H., An, H., Kim, N., Chae, H., Kim, H., Song, H., Kim, K.-Y., Baek, S., et al. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:3:191 · Cited by 96
Zaremba, J., Skrobański, P., & Losy, J. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00058-0 · Cited by 83
Time course of IL-6 expression in experimental CNS ischemia
Clark, W. M., Rinker, L. G., Lessov, N. S., Hazel, K., & Eckenstein, F. P. (1999) · Neurological Research · doi:10.1080/01616412.1999.11740933 · Cited by 81
Inadera, H., Sekiya, T., Yoshimura, T., & Matsushima, K. (2000) · Endocrinology · doi:10.1210/endo.141.1.7233 · Cited by 64
Mitogenic effects of interleukin-5 on microglia
Ringheim, G. E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12153-6 · Cited by 45
IL-5 Induces Proliferation and Activation of Microglia via an Unknown Receptor
Liva, S. M., & de Vellis, J. (2001) · Neurochemical Research · doi:10.1023/a:1010983119125 · Cited by 44
Women, hormones, and clinical trials: a beginning, not an end
Miller, V. M., Clarkson, T. B., Harman, S. M., Brinton, E. A., Cedars, M. I., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., & Santoro, N. F. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00248.2005 · Cited by 31
Cited by
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Estrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423
Uncovering the mechanisms of estrogen effects on hippocampal function
Spencer, J. L., Waters, E. M., Romeo, R. D., Wood, G. E., Milner, T. A., & McEwen, B. S. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.006 · Cited by 414
Estrogen and Mechanisms of Vascular Protection
Xing, D., Nozell, S., Chen, Y.-F., Hage, F., & Oparil, S. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182279 · Cited by 379
Vegeto, E., Benedusi, V., & Maggi, A. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 355
Metadata
- Authors
- Suzuki, S., Brown, C. M., Dela Cruz, C. D., Yang, E., Bridwell, D. A., & Wise, P. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-04-03
- Volume
- 104
- Issue
- 14
- Pages
- 6013-6018
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W17389368
- Cited by
- 256
- References
- 48
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.